Trulieve describes itself as having leading market positions in Arizona, Florida, and Pennsylvania. The company operates more than 200 retail dispensaries and over four million square feet of cultivation and processing capacity, selling over 12 million branded products per quarter.
Cyborg Score Rationale
Strong operational metrics with $1.2B revenue, 60% gross margin, and record free cash flow of $229 million. However, profitability remains challenged with negative net income. Positioned well for regulatory tailwinds from potential cannabis rescheduling.
Top Insights
Company publicly supported Trump Administration's decision to reclassify marijuana to Schedule III under the Controlled Substances Act
Completed refinancing with 10.5% senior secured notes due 2030 while redeeming $368M of 8.0% notes due 2026, intending to use proceeds for capital expenditures
Operates dispensaries across Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania
Record 2025 cash generation demonstrates strong operational leverage and path to profitability
Named Competitors
Curaleaf Holdings — Multi-state cannabis retailer and cultivator